I refuse to sell because the 90% red reminds me I'm ape. The £30 left is the price to pay for literally spinning a stock list and choosing one. On the bright side, it also gives confidence that my other …
Markets are moving on-chain. Perps already made that trip. They started as a way to trade with leverage around the clock, became the default, and on Hyperliquid they spread to stocks, indexes, oil, and companies that are not even public. …
VisionWave put out an update this morning on the air and counter-drone part of their autonomous defense work. They’re tying it to the same STRATUM ground platforms. Contemplated systems include TALON 10 for ISR, a heavy-lift version for logistics, a …
RYET just guided to $9.3M-$9.5M in preliminary H1 FY2027 revenue, up more than 24x YoY from about $0.37M in H1 FY2026 and already above the $7.48M generated in all of FY2026. At the same time, the company delivered its $880K …
Some very interesting developments in the last 2 weeks. For those with short attention spans, the TLRD version: 1) Lucid started submitting Medicare claims in September. 2) The screening population is expanding. Supporting information on point #1: Lucid issued a …
Some stocks I’m watching $**NXGB** for the 002 break ceo resigned and new folks took over. $**TIPS** for a possible break out of trips. $**PNXP** a low float trips play lotto. The company has shifted its public description. Earlier materials …
Chegg’s student subscription business has struggled since generative AI became widely available. Meanwhile, companies such as Scale AI, Mercor, and Turing have built valuable businesses around the people, data, and evaluations used to improve AI models. Now Chegg is recruiting …
A beat of their FY26 guidance with the company shaping up nicely to take advantage of growing markets in space & communications, photonics, automotive and industrial chip design and supply. Read the full London Stock Exchange announcement here… [https://www.londonstockexchange.com/news-article/ENSI/final-results/17820518](https://www.londonstockexchange.com/news-article/ENSI/final-results/17820518)
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
Setup over the next 6 months is interesting and maybe being ignored by the market. My thesis is based on a few possible catalysts: 1. China / Simcere approval catalyst CNTB’s partner Simcere has completed Phase 3 for rademikibart in …